Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, etc) & Companies
Global Cardiac Marker Analyzer Market is projected to cross US$ 4 Billion by the year 2024. Cardiac Marker Analyzer (Cardiac Reader Systems) offers high point of care testing results for the diagnosis of cardiac related diseases like myocardial infarction and others. Cardiac Marker Analyzer performs all cardiac monitoring tests such as Troponin, Myoglobin, CK-MB and D-Dimer tests, through immunochromatographic assays. Cardiac marker analyzer efficiency and accuracy can be increased with the help of dedicated software and system which offers extensive support to diagnostic procedures and built in LCD displays for the visualization of practices.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Some of the major Cardiac Marker Analyzers which are frequently used in the diagnosis of patient’s cardiac conditions include i–STAT System, RAMP Reader, RAMP 200, QL Care Analyzer, Access 2 Immunoassay System, Meritas POC Analyzer, Alere Meterpro Analyzer, PATHFAST Analyzer, Stratus CS Analyzer, Cobas H 232 POC System, ichroma DUO Analyzer and DXpress Reader Analyzer.
Cardiac Marker Analyzers plays an important role in the prevention of the misdiagnoses of heart conditions. Increasing prevalence of heart related diseases across the globe and growing awareness among people about the cardiovascular diseases is expected to drive the demand of Cardiac Marker Analyzers for the diagnosis of cardiac diseases.
Renub Research report titled “Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, The i–STAT System, cobas h 232 POC System, Stratus CS Analyzer, Access 2 Immunoassay System, ichroma DUO Analyzer, DXpress Reader Analyzer, PATHFAST Analyzer, Meritas POC Analyzer, QL Care Analyzer), Companies (Abbott Laboratories, Getein Biotechnology, Siemens Healthcare, Beckman-Coulter, Alere, Response Biomedical, Roche Diagnostics, Boditech, LifeSign, LSI Medience Corporation, Trinity Biotech, CardioGenics)” provides a complete analysis of Cardiac Marker Analyzer Products.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
1. Cardiac Marker Analyzer Market
2. Analyzer Specifications and Benefits
3. Net Product Sales
4. Merger, Acquisition & Licensing Agreement
5. Marketing Strategies
6. Methods of Distribution
12 Cardiac Marker Analyzer studied in the report are as follows:
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. cobas h 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
Company Analysis
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Some of the major Cardiac Marker Analyzers which are frequently used in the diagnosis of patient’s cardiac conditions include i–STAT System, RAMP Reader, RAMP 200, QL Care Analyzer, Access 2 Immunoassay System, Meritas POC Analyzer, Alere Meterpro Analyzer, PATHFAST Analyzer, Stratus CS Analyzer, Cobas H 232 POC System, ichroma DUO Analyzer and DXpress Reader Analyzer.
Cardiac Marker Analyzers plays an important role in the prevention of the misdiagnoses of heart conditions. Increasing prevalence of heart related diseases across the globe and growing awareness among people about the cardiovascular diseases is expected to drive the demand of Cardiac Marker Analyzers for the diagnosis of cardiac diseases.
Renub Research report titled “Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, The i–STAT System, cobas h 232 POC System, Stratus CS Analyzer, Access 2 Immunoassay System, ichroma DUO Analyzer, DXpress Reader Analyzer, PATHFAST Analyzer, Meritas POC Analyzer, QL Care Analyzer), Companies (Abbott Laboratories, Getein Biotechnology, Siemens Healthcare, Beckman-Coulter, Alere, Response Biomedical, Roche Diagnostics, Boditech, LifeSign, LSI Medience Corporation, Trinity Biotech, CardioGenics)” provides a complete analysis of Cardiac Marker Analyzer Products.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
1. Cardiac Marker Analyzer Market
2. Analyzer Specifications and Benefits
3. Net Product Sales
4. Merger, Acquisition & Licensing Agreement
5. Marketing Strategies
6. Methods of Distribution
12 Cardiac Marker Analyzer studied in the report are as follows:
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. cobas h 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer
Company Analysis
- Abbott Laboratories
- Getein Biotechnology
- Siemens Healthcare
- Beckman-Coulter
- Alere
- Response Biomedical
- Roche Diagnostics
- Boditech
- LifeSign
- LSI Medience Corporation
- Trinity Biotech
- CardioGenics
1. EXECUTIVE SUMMARY
2. CARDIAC MARKER ANALYZER MARKET (2011 – 2024)
3. CARDIAC MARKER COMPANIES – COMPARATIVE TESTS ANALYSIS
4. CARDIAC MARKER ANALYZER – COMPETITIVE PRODUCT ANALYSIS
5. ALERE
5.1 Alere Triage
5.1.1 Triage MeterPro Analyzer
5.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
6. RESPONSE BIOMEDICAL
6.1 Cardiovascular Testing
6.1.1 Acute Myocardial Infarction (Heart Attack) Testing
6.1.2 Congestive Heart Failure (“CHF”) Testing
6.1.3 Thrombotic Disease Testing
6.2 RAMP Platform
6.2.1 RAMP
6.2.2 RAMP Reader
6.3 Response Biomedical Cardiovascular Net Sales
7. ABBOTT POINT OF CARE
7.1 The i–STAT System
7.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2024)
8. ROCHE
8.1 Cobas h 232 POC System
9. SIEMENS HEALTHINEERS
9.1 Stratus CS Analyzer
9.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare
10. BECKMAN COULTER
10.1 Access 2 Immunoassay System
11. BODITECH
11.1 i–chroma DUO Analyzer
12. LIFESIGN
12.1 DXpress Reader Analyzer
13. LSI MEDIENCE CORPORATION
13.1 PATHFAST Analyzer
14. TRINITY BIOTECH
14.1 Meritas POC Analyzer
14.2 Trinity Biotech Point of Care Diagnostics Sales (2011 – 2024)
15. CARDIOGENICS HOLDINGS INC.
15.1 QL Care Analyzer
16. MERGERS, ACQUISITIONS AND LICENSING AGREEMENTS
16.1 Alere Inc
16.2 Response Biomedical
16.3 Abbott Laboratories
16.4 Siemens Healthineers
16.5 LSI Medience Corporation
16.6 Trinity Biotech
16.7 CardioGenics
17. EMERGING MARKERS
18. RESPONSE BIOMEDICAL – BUSINESS & MARKETING STRATEGY
18.1 Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy
18.2 New Distributors in China
18.3 Strategic Alliances with Alere Medical in Japan
18.4 Response Biomedical Receives Health Canada Approval and CE Mark
19. ROCHE – BUSINESS & MARKETING STRATEGY
19.1 Implementing the Fully Connected Core Laboratory
19.2 Expansion of Rich Test Menu
19.3 Broadening the Diagnostics Portfolio
19.4 Patient Safety Comes First
20. SIEMENS HEALTHINEERS – BUSINESS AND MARKETING STRATEGY
20.1 Siemens Healthineers Announces New Strategic Relationship
20.2 Cloud-Based Network Teamplay from Siemens Healthineers
20.3 Strategic Partnership between Siemens and Imricor
20.4 Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
20.5 Siemens Healthineers & Digitalization
20.6 Partnership between Siemens Healthineers and Ebit
21. BODITECH MED INC – BUSINESS AND MARKETING STRATEGY
21.1 Boditech Med Acquires Immunostics
21.2 Strong Focus on Manpower and Investments in Research & Development Area
21.3 Advanced Technology in the Diagnostics Market
21.4 Marketing Channel
2. CARDIAC MARKER ANALYZER MARKET (2011 – 2024)
3. CARDIAC MARKER COMPANIES – COMPARATIVE TESTS ANALYSIS
4. CARDIAC MARKER ANALYZER – COMPETITIVE PRODUCT ANALYSIS
5. ALERE
5.1 Alere Triage
5.1.1 Triage MeterPro Analyzer
5.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)
6. RESPONSE BIOMEDICAL
6.1 Cardiovascular Testing
6.1.1 Acute Myocardial Infarction (Heart Attack) Testing
6.1.2 Congestive Heart Failure (“CHF”) Testing
6.1.3 Thrombotic Disease Testing
6.2 RAMP Platform
6.2.1 RAMP
6.2.2 RAMP Reader
6.3 Response Biomedical Cardiovascular Net Sales
7. ABBOTT POINT OF CARE
7.1 The i–STAT System
7.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2024)
8. ROCHE
8.1 Cobas h 232 POC System
9. SIEMENS HEALTHINEERS
9.1 Stratus CS Analyzer
9.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare
10. BECKMAN COULTER
10.1 Access 2 Immunoassay System
11. BODITECH
11.1 i–chroma DUO Analyzer
12. LIFESIGN
12.1 DXpress Reader Analyzer
13. LSI MEDIENCE CORPORATION
13.1 PATHFAST Analyzer
14. TRINITY BIOTECH
14.1 Meritas POC Analyzer
14.2 Trinity Biotech Point of Care Diagnostics Sales (2011 – 2024)
15. CARDIOGENICS HOLDINGS INC.
15.1 QL Care Analyzer
16. MERGERS, ACQUISITIONS AND LICENSING AGREEMENTS
16.1 Alere Inc
16.2 Response Biomedical
16.3 Abbott Laboratories
16.4 Siemens Healthineers
16.5 LSI Medience Corporation
16.6 Trinity Biotech
16.7 CardioGenics
17. EMERGING MARKERS
18. RESPONSE BIOMEDICAL – BUSINESS & MARKETING STRATEGY
18.1 Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy
18.2 New Distributors in China
18.3 Strategic Alliances with Alere Medical in Japan
18.4 Response Biomedical Receives Health Canada Approval and CE Mark
19. ROCHE – BUSINESS & MARKETING STRATEGY
19.1 Implementing the Fully Connected Core Laboratory
19.2 Expansion of Rich Test Menu
19.3 Broadening the Diagnostics Portfolio
19.4 Patient Safety Comes First
20. SIEMENS HEALTHINEERS – BUSINESS AND MARKETING STRATEGY
20.1 Siemens Healthineers Announces New Strategic Relationship
20.2 Cloud-Based Network Teamplay from Siemens Healthineers
20.3 Strategic Partnership between Siemens and Imricor
20.4 Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
20.5 Siemens Healthineers & Digitalization
20.6 Partnership between Siemens Healthineers and Ebit
21. BODITECH MED INC – BUSINESS AND MARKETING STRATEGY
21.1 Boditech Med Acquires Immunostics
21.2 Strong Focus on Manpower and Investments in Research & Development Area
21.3 Advanced Technology in the Diagnostics Market
21.4 Marketing Channel
LIST OF FIGURES
Figure 2-1: Global – Cardiac Marker Market (Billion US$), 2011 - 2017
Figure 2-2: Global – Forecast For Cardiac Marker Market (Billion US$), 2018 – 2024
Figure 5-1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016
Figure 6-1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016
Figure 7-1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2017
Figure 7-2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2018 – 2024
Figure 8-1: WIFI Set-up
Figure 8-2: QR CODE VIA BARCODE SCANNER Set-up
Figure 8-3: QR CODE VIA SMART PHONE APP Set-up
Figure 8-4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up
Figure 14-1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2017
Figure 14-2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2018 – 2024
Figure 21-1: Boditech – R&D Manpower, Jan 2016
Figure 21-2: Boditech – R&D Investments (Million US$), Jan 2016
Figure 2-1: Global – Cardiac Marker Market (Billion US$), 2011 - 2017
Figure 2-2: Global – Forecast For Cardiac Marker Market (Billion US$), 2018 – 2024
Figure 5-1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016
Figure 6-1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016
Figure 7-1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2017
Figure 7-2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2018 – 2024
Figure 8-1: WIFI Set-up
Figure 8-2: QR CODE VIA BARCODE SCANNER Set-up
Figure 8-3: QR CODE VIA SMART PHONE APP Set-up
Figure 8-4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up
Figure 14-1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2017
Figure 14-2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2018 – 2024
Figure 21-1: Boditech – R&D Manpower, Jan 2016
Figure 21-2: Boditech – R&D Investments (Million US$), Jan 2016
LIST OF TABLES
Table 2-1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2-2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2-3: Cardiac Marker Companies – Comparative Tests Analysis
Table 3-1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3-2: Cardiac Marker Analyzer – Competitive Product Analysis
Table 6-1: i-STAT 1 Analyzer Specification
Table 12-1: PATHFAST – Technical Specifications
Table 15-1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017
Table 18-1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
Table 18-2: Roche - Molecular Diagnostics Product Launches, 2017
Table 18-3: Roche - Tissue Diagnostics Product Launches, 2017
Table 18-4: Roche - Sequencing Product Launches, 2017
Table 2-1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2-2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2-3: Cardiac Marker Companies – Comparative Tests Analysis
Table 3-1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3-2: Cardiac Marker Analyzer – Competitive Product Analysis
Table 6-1: i-STAT 1 Analyzer Specification
Table 12-1: PATHFAST – Technical Specifications
Table 15-1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017
Table 18-1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
Table 18-2: Roche - Molecular Diagnostics Product Launches, 2017
Table 18-3: Roche - Tissue Diagnostics Product Launches, 2017
Table 18-4: Roche - Sequencing Product Launches, 2017
